Warnings
2-MMC (98%); Ketamine (2%) Upptäckt 2-MMC 98%, Ketamine 2%. Plats: Marseille, Frankrike. Datum: 2025-11-13. Källa: druglab.fr.
2-MMC (98%); Ketamine (2%)-tablett — Marseille, Frankrike — 2025-11-13
Detected 2-MMC 98%, Ketamine 2%
Expected Unknown
Logo Unknown
Color brown
Location Marseille, France
Date 2025-11-13
Source druglab.fr
Media 1 image Appearance Color: brown Media: 1 sample photo Expected vs Detected No expected substance was recorded for this sample.
Detected result: 2-MMC 98%, Ketamine 2%
Sample Details No additional sample descriptors available.
Testing Context Location: Marseille, Frankrike Date tested: 2025-11-13 Source: druglab.fr Harm Reduction Similar-looking pills can contain different substances or strengths. Use drug checking services when available. Start low and avoid assuming a logo identifies the contents. SampleDNA Beta 2103 anslutna varningar · Lär dig mer om vanliga föroreningar.
Relaterade prover och kombinationer 2-MMC + Ketamine 30 prover · Nuvarande resultat
Upptäckta tillsammans i relaterade drogkontroller.
Xanax logotyp 212 prover
Samma logotyp visas i relaterade droganalysresultat.
Flualprazolam Xanax, 2 · Vienna, Österrike · 2026-08-24 Methylclonazepam Xanax · Powys (LD3), Wales · 2026-07-23 Alprazolam Xanax · Kensington and Chelsea, Wandsworth, Westminster (SW1W), England · 2026-07-23 Bromazolam Xanax · Argyll and Bute, West Dunbartonshire (G82), Storbritannien · 2026-07-16 Alprazolam Xanax · City of Edinburgh, Midlothian (EH10), Storbritannien · 2026-07-16 Bromazolam Xanax · Kirklees (HD4), England · 2026-07-16 2-MMC + 4-MMC + Ketamine 2 prover
Upptäckta tillsammans i relaterade drogkontroller.
2-MMC + 2C-B + Ketamine + MDMA + Unknown 1 prov
Upptäckta tillsammans i relaterade drogkontroller.
2-MMC + 3-CMC + Caffeine + Cocaine + iso-LSD + Ketamine + LSD + MDMA + Methylon + Tertramisol (3,6µg (Mikrogramm)) 1 prov
Upptäckta tillsammans i relaterade drogkontroller.
SampleDNA-utforskare
Links This static page is intended as the readable export baseline for crawler and low-capability delivery.